| Date | Time | Source | Announcement |
|---|---|---|---|
| 30 Apr 2003 | 11:00 AM | Directorate Change | |
| 30 Apr 2003 | 10:00 AM | 1st Quarter Results | |
| 30 Apr 2003 | 10:00 AM | 1st Quarter Results | |
| 22 Apr 2003 | 04:47 PM | Capital Group | |
| 02 Apr 2003 | 03:51 PM | Exanta | |
| 01 Apr 2003 | 07:00 AM | Nexium | |
| 01 Apr 2003 | 07:00 AM | Purchase of Own Securities | |
| 31 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 26 Mar 2003 | 04:00 PM | Director Shareholding | |
| 13 Mar 2003 | 07:13 AM | Purchase of Own Securities | |
| 11 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 10 Mar 2003 | 07:00 AM | Crestor MRP Completion | |
| 10 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 07 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 05 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 03 Mar 2003 | 07:00 AM | Crestor in Europe | |
| 03 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
| 27 Feb 2003 | 12:21 PM | Annual Report and Accounts | |
| 26 Feb 2003 | 07:00 AM | Purchase of Own Securities | |
| 19 Feb 2003 | 07:00 AM | Crestor | |
| 18 Feb 2003 | 07:00 AM | Research Update: AZD3582 | |
| 17 Feb 2003 | 07:00 AM | Exanta Sportif | |
| 13 Feb 2003 | 07:01 AM | Crestor | |
| 11 Feb 2003 | 09:00 AM | Iressa | |
| 30 Jan 2003 | 11:00 AM | Final Results (part 2 of 2) | |
| 30 Jan 2003 | 11:00 AM | Final Results (part 1 of 2) | |
| 29 Jan 2003 | 09:00 AM | Notice of Results | |
| 14 Jan 2003 | 04:00 PM | Capital Group | |
| 10 Jan 2003 | 03:00 PM | Capital Group | |
| 09 Jan 2003 | 03:00 PM | Update on Iressa | |
| 02 Jan 2003 | 01:30 PM | Seroquel | |
| 23 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 20 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 19 Dec 2002 | 07:09 AM | Casodex | |
| 19 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 16 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 13 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 12 Dec 2002 | 10:00 AM | Omeprazole Judgment | |
| 12 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 11 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 06 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 05 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 04 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 02 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
| 29 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 28 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 27 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 26 Nov 2002 | 04:07 PM | Director Shareholding | |
| 26 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 25 Nov 2002 | 07:00 AM | Purchase of Own Securities |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.